ANX 8.33% 2.6¢ anax metals limited

approval for us sales of travelan

  1. 13,013 Posts.
    lightbulb Created with Sketch. 99
    Travelan has been assessed in the United States and given the green light to be sold into the
    commercially significant North American market.
    Research, review and analysis of Anadis’ Travelan –hyper immunized colostrum powder- as
    well as history of use and safety / toxicology evidence, has received US legal opinion that
    Travelan is in compliance with all US Federal and State regulations for sale in the Dietary and
    Medical Food categories.
    Travelan and Travellers’ Diarrhoea
    Travelan – Anadis’ lead product – is a revolutionary over-the-counter (OTC) preparation
    scientifically and clinically proven to significantly reduce the risk of getting the medical
    condition known as Travellers’ Diarrhoea (otherwise known as Delhi Belly, Montezuma’s
    Revenge, Tourist Trots and The Flux etc). Travellers’ Diarrhoea is described as the number
    one health problem for international travellers, in terms of frequency and economic impact.
    Travellers’ Diarrhoea is normally accompanied by other clinical features such as nausea,
    vomiting, abdominal cramps and fever. Travelan is based on antibody technology and not an
    antibiotic preparation. Unlike conventional treatment medications, Travelan significantly
    reduces the risk of being affected in the first instance.
    Commercial Opportunities for Travelan
    With more than 22 million US travellers per year to “High Risk” areas (this figure does not
    include travel to “medium risk” or “low risk” areas) the US is a very significant market for
    Anadis. Medical statistics show that, on average, over 40% of travellers will be somehow
    affected by Travellers’ Diarrhoea.
    This “green light” is an important and exciting step for the international expansion of Travelan.
    Anadis is currently in discussions with prospective partners in the US market to begin sales of
    Travelan at the earliest opportunity.
    In addition, Anadis is also actively working on registration in other international markets
    including Canada, Singapore, Hong Kong, India, Thailand, Taiwan, Malaysia, United
    Kingdom and Europe.
    For more information about Travelan visit www.travelan.com.au
 
watchlist Created with Sketch. Add ANX (ASX) to my watchlist
(20min delay)
Last
2.6¢
Change
0.002(8.33%)
Mkt cap ! $17.97M
Open High Low Value Volume
2.4¢ 2.7¢ 2.4¢ $63.17K 2.490M

Buyers (Bids)

No. Vol. Price($)
2 33200 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 41808 1
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
ANX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.